Roble Belko & Company’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-205
| Closed | -$17K | – | 320 |
|
|
2020
Q1 | $17K | Hold |
205
| – | – | 0.01% | 198 |
|
|
2019
Q4 | $17K | Hold |
205
| – | – | ﹤0.01% | 229 |
|
|
2019
Q3 | $14K | Hold |
205
| – | – | ﹤0.01% | 237 |
|
|
2019
Q2 | $18K | Hold |
205
| – | – | 0.01% | 207 |
|
|
2019
Q1 | $18K | Hold |
205
| – | – | 0.01% | 175 |
|
|
2018
Q4 | $17K | Hold |
205
| – | – | 0.01% | 161 |
|
|
2018
Q3 | $20K | Hold |
205
| – | – | 0.01% | 160 |
|
|
2018
Q2 | $19K | Sell |
205
-633
| -76% | -$58.7K | 0.01% | 168 |
|
|
2018
Q1 | $68K | Buy |
838
+238
| +40% | +$19.3K | 0.03% | 105 |
|
|
2017
Q4 | $54K | Buy |
+600
| New | +$54K | 0.02% | 111 |
|
|
2017
Q2 | – | Sell |
-39
| Closed | -$3K | – | 304 |
|
|
2017
Q1 | $3K | Hold |
39
| – | – | ﹤0.01% | 285 |
|
|
2016
Q4 | $3K | Buy |
+39
| New | +$3K | ﹤0.01% | 303 |
|